Tumor specific transplantation antigens (ATS) are antigens that can be detected in experimental animals when they are transplanted with tumor cells. These antigens are specific for a given tumor type and can be used as markers for the diagnosis and treatment of cancer.
A. o.s. can be found in the blood, urine, saliva and other biological fluids of animals. They are proteins that are expressed on the surface of tumor cells and can be used to identify a patient's cancer.
There are several methods for detecting A. o.s., including enzyme-linked immunosorbent assay, immunoblotting, and polymerase chain reaction. Each of these methods has its own advantages and disadvantages, but they all provide accurate results.
Detection of A. o.s. can be used to diagnose cancer, as well as to determine the effectiveness of treatment. For example, if A. o.s. disappear after chemotherapy, this may indicate that the treatment was effective.
In general, A. o.s. are an important tool in the diagnosis and treatment of cancer, and their use can help improve the quality of life of patients.
Tumor specific antigens (ATS) are proteins foreign to the body that are formed in tumors and help tumor cells to actively grow. They are also foreign to other cells in the body, including T cells that protect against infection. Often the presence of these proteins confirms cancer.